Writing on the occassion of thee BIO conference in Boston and professor Jim Kim’s National Day of Action address at Harvard, the Globe highlighted UAEM’s proposals as one of the key ways to ensure that new biotechnology advances are “not just for the rich.” The full text of the editorial is after the jump.
Other prominent […]

As the fight for affordable AIDS treatment comes to a head around the world, with litigation in India, a showdown in Thailand, and heated debate in the U.S. Congress, UAEM’s growing national student movement erupted on nearly 50 campuses, demanding universities recognize their own role in the access crisis. Students at almost 50 top […]

On September 28, Senator Leahy introduced legislation that would require all federally-funded research institutions to ensure that the drugs they develop are supplied to poor countries at the lowest possible cost: The Public Research in the Public Interest Act of 2006 (S. 4040). In recognition that universities have failed to act on an […]

UAEM’s Statement of Principles is included in the recently released report by the WHO’s Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH; http://www.who.int/intellectualproperty, see section on Public Sector and University Patenting, p. 73). The Commission was formed in 2004 to study how current intellectual property regimes and other incentive and funding mechanisms are […]